Europe Cannabidiol (CBD) Market Size, Share & Trends Analysis Report By Source Type (Hemp, Marijuana), By Sales Type (B2B, B2C), By End-use (Medical, Personal Use), By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Source Type
                        1.2.2. Sales Type
                        1.2.3. End-use
                        1.2.4. Country scope
                        1.2.5. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in Europe
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Source type outlook
                        2.2.2. Sales type outlook
                        2.2.3. End-use outlook
                        2.2.4. Country outlook
                    2.3. Competitive Insights
Chapter 3. Europe Cannabidiol Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Growing legalization of CBD-based products
                            3.2.1.2. Increasing preference for cannabis oils and tinctures
                            3.2.1.3. Growing adoption of CBD-based products for treating various medical conditions
                            3.2.1.4. Rise in number of retailers selling CBD-based products
                        3.2.2. Market restraint analysis
                            3.2.2.1. Stringent government regulations
                            3.2.2.2. High cost of CBD in leading markets
                    3.3. Europe Cannabidiol Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s Five Forces
                        3.3.2. PESTEL Analysis
                    3.4. COVID-19 Impact Analysis
Chapter 4. Europe Cannabidiol Market: Source Type Estimates & Trend Analysis
                    4.1. Europe Cannabidiol Market: Source Type Dashboard
                    4.2. Europe Cannabidiol Market: Source Type Movement Analysis
                    4.3. Europe Cannabidiol Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    4.4. Hemp
                        4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                    4.5. Marijuana
                        4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Europe Cannabidiol Market: Sales Type Estimates & Trend Analysis
                    5.1. Europe Cannabidiol Market: Sales Type Dashboard
                    5.2. Europe Cannabidiol Market: Sales Type Movement Analysis
                    5.3. Europe Cannabidiol Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    5.4. Business to Business (B2B)
                        5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                    5.5. Business to Consumer (B2C)
                        5.5.1. Hospital Pharmacies
                            5.5.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.5.2. Online Stores
                            5.5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        5.5.3. Retail Stores
                            5.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Europe Cannabidiol Market: End-use Estimates & Trend Analysis
                    6.1. Europe Cannabidiol Market: End-use Dashboard
                    6.2. Europe Cannabidiol Market: End-use Movement Analysis
                    6.3. Europe Cannabidiol Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    6.4. Medical
                        6.4.1. Chronic Pain
                            6.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.4.2. Mental Disorders
                            6.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.4.3. Cancer
                            6.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.4.4. Others
                            6.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                    6.5. Personal Use
                        6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                    6.6. Pharmaceutical
                        6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                    6.7. Wellness
                        6.7.1. Food & Beverages
                            6.7.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.7.2. Personal care & Cosmetics
                            6.7.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.7.3. Nutraceutical
                            6.7.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                        6.7.4. Others
                            6.7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Regional Estimates & Trend Analysis by Source Type, Sales Type, End-use
                    7.1. Europe Cannabidiol Market: Regional Dashboard
                    7.2. Europe Cannabidiol Market: Regional Movement Analysis
                    7.3. Europe Cannabidiol Market Size & Forecasts and Trend Analyses by Source Type, Sales Type, End-use, 2018 to 2030
                    7.4. Europe
                        7.4.1. UK
                            7.4.1.1. Key country dynamics
                            7.4.1.2. Regulatory framework/ reimbursement structure
                            7.4.1.3. Competitive scenario
                            7.4.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
                        7.4.2. Germany
                            7.4.2.1. Key country dynamics
                            7.4.2.2. Regulatory framework/ reimbursement structure
                            7.4.2.3. Competitive scenario
                            7.4.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
                        7.4.3. Netherlands
                            7.4.3.1. Key country dynamics
                            7.4.3.2. Regulatory framework/ reimbursement structure
                            7.4.3.3. Competitive scenario
                            7.4.3.4. Netherlands market estimates and forecasts, 2018 - 2030 (USD Million)
                        7.4.4. Switzerland
                            7.4.4.1. Key country dynamics
                            7.4.4.2. Regulatory framework/ reimbursement structure
                            7.4.4.3. Competitive scenario
                            7.4.4.4. Switzeland market estimates and forecasts, 2018 - 2030 (USD Million)
                        7.4.5. Italy
                            7.4.5.1. Key country dynamics
                            7.4.5.2. Regulatory framework/ reimbursement structure
                            7.4.5.3. Competitive scenario
                            7.4.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
                        7.4.6. France
                            7.4.6.1. Key country dynamics
                            7.4.6.2. Regulatory framework/ reimbursement structure
                            7.4.6.3. Competitive scenario
                            7.4.6.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
                        7.4.7. Poland
                            7.4.7.1. Key country dynamics
                            7.4.7.2. Regulatory framework/ reimbursement structure
                            7.4.7.3. Competitive scenario
                            7.4.7.4. Poland market estimates and forecasts, 2018 - 2030 (USD Million)
                        7.4.8. Czech Republic
                            7.4.8.1. Key country dynamics
                            7.4.8.2. Regulatory framework/ reimbursement structure
                            7.4.8.3. Competitive scenario
                            7.4.8.4. Czech Republic market estimates and forecasts, 2018 - 2030 (USD Million)
                        7.4.9. Croatia
                            7.4.9.1. Key country dynamics
                            7.4.9.2. Regulatory framework/ reimbursement structure
                            7.4.9.3. Competitive scenario
                            7.4.9.4. Croatia market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis, By Key Market Participants
                    8.2. Company/Competition Categorization
                    8.3. Vendor Landscape
                        8.3.1. Key customers
                        8.3.2. Key company market share analysis, 2023
                        8.3.3. Jazz Pharmaceuticals
                            8.3.3.1. Company overview
                            8.3.3.2. Financial performance
                            8.3.3.3. Product benchmarking
                            8.3.3.4. Strategic initiatives
                        8.3.4. Canopy Growth Corporation
                            8.3.4.1. Company overview
                            8.3.4.2. Financial performance
                            8.3.4.3. Product benchmarking
                            8.3.4.4. Strategic initiatives
                        8.3.5. Tilray
                            8.3.5.1. Company overview
                            8.3.5.2. Financial performance
                            8.3.5.3. Product benchmarking
                            8.3.5.4. Strategic initiatives
                        8.3.6. Aurora Cannabis
                            8.3.6.1. Company overview
                            8.3.6.2. Financial performance
                            8.3.6.3. Product benchmarking
                            8.3.6.4. Strategic initiatives
                        8.3.7. Maricann, Inc.
                            8.3.7.1. Company overview
                            8.3.7.2. Financial performance
                            8.3.7.3. Product benchmarking
                            8.3.7.4. Strategic initiatives
                        8.3.8. Organigram Holding, Inc.
                            8.3.8.1. Company overview
                            8.3.8.2. Financial performance
                            8.3.8.3. Product benchmarking
                            8.3.8.4. Strategic initiatives
                        8.3.9. Isodiol International, Inc.
                            8.3.9.1. Company overview
                            8.3.9.2. Financial performance
                            8.3.9.3. Product benchmarking
                            8.3.9.4. Strategic initiatives
                        8.3.10. Medical Marijuana, Inc.
                            8.3.10.1. Company overview
                            8.3.10.2. Financial performance
                            8.3.10.3. Product benchmarking
                            8.3.10.4. Strategic initiatives
                        8.3.11. Elixinol
                            8.3.11.1. Company overview
                            8.3.11.2. Financial performance
                            8.3.11.3. Product benchmarking
                            8.3.11.4. Strategic initiatives
                        8.3.12. NuLeaf Naturals, LLC
                            8.3.12.1. Company overview
                            8.3.12.2. Financial performance
                            8.3.12.3. Product benchmarking
                            8.3.12.4. Strategic initiatives
                        8.3.13. Cannoid, LLC
                            8.3.13.1. Company overview
                            8.3.13.2. Financial performance
                            8.3.13.3. Product benchmarking
                            8.3.13.4. Strategic initiatives
                        8.3.14. CV Sciences, Inc.
                            8.3.14.1. Company overview
                            8.3.14.2. Financial performance
                            8.3.14.3. Product benchmarking
                            8.3.14.4. Strategic initiatives
                        8.3.15. CHARLOTTE’S WEB.
                            8.3.15.1. Company overview
                            8.3.15.2. Financial performance
                            8.3.15.3. Product benchmarking
                            8.3.15.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Europe cannabidiol market, by region, 2018 - 2030 (USD Million)
Table 3 Europe cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 4 Europe cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 5 Europe cannabidiol market, by end-use, 2018 - 2030 (USD Million)
Table 6 UK cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 7 UK cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 8 UK cannabidiol market, by end-use, 2018 - 2030 (USD Million)
Table 9 Germany cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 10 Germany cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 11 Germany cannabidiol market, by end-use, 2018 - 2030 (USD Million)
Table 12 Netherlands cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 13 Netherlands cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 14 Netherlands cannabidiol market, by end-use, 2018 - 2030 (USD Million)
Table 15 Switzerland cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 16 Switzerland cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 17 Switzerland cannabidiol market, by end-use, 2018 - 2030 (USD Million)
Table 18 Italy cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 19 Italy cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 20 Italy cannabidiol market, by end-use, 2018 - 2030 (USD Million)
Table 21 France cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 22 France cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 23 France cannabidiol market, by end-use, 2018 - 2030 (USD Million)
Table 24 Poland cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 25 Poland cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 26 Poland cannabidiol market, by end-use, 2018 - 2030 (USD Million)
Table 27 Czech Republic cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 28 Czech Republic cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 29 Czech Republic cannabidiol market, by end-use, 2018 - 2030 (USD Million)
Table 30 Croatia cannabidiol market, by source type, 2018 - 2030 (USD Million)
Table 31 Croatia cannabidiol market, by sales type, 2018 - 2030 (USD Million)
Table 32 Croatia cannabidiol market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in Europe
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Europe cannabidiol market: market outlook
Fig. 10 Europe cannabidiol competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Industry value chain analysis
Fig. 14 Europe cannabidiol market driver impact
Fig. 15 Europe cannabidiol market restraint impact
Fig. 16 Europe cannabidiol market: Source type movement analysis
Fig. 17 Europe cannabidiol market: Source type outlook and key takeaways
Fig. 18 Hemp market estimates and forecast, 2018 - 2030
Fig. 19 Marijuana market estimates and forecast, 2018 - 2030
Fig. 20 Europe cannabidiol market: Sales type movement Analysis
Fig. 21 Europe cannabidiol market: Sales type outlook and key takeaways
Fig. 22 B2B market estimates and forecasts, 2018 - 2030
Fig. 23 B2C market estimates and forecasts, 2018 - 2030
Fig. 24 Europe cannabidiol market: End-use movement analysis
Fig. 25 Europe cannabidiol market: End-use outlook and key takeaways
Fig. 26 Medical market estimates and forecasts, 2018 - 2030
Fig. 27 Personal use market estimates and forecasts, 2018 - 2030
Fig. 28 Pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 29 Wellness market estimates and forecasts, 2018 - 2030
Fig. 30 Europe cannabidiol market: Regional movement analysis
Fig. 31 Europe cannabidiol market: Regional outlook and key takeaways
Fig. 32 Europe cannabidiol market share and leading players
Fig. 33 Europe market share and leading players
Fig. 34 Europe: SWOT
Fig. 35 Europe, by country
Fig. 36 Europe
Fig. 37 Europe market estimates and forecasts, 2018 - 2030
Fig. 38 UK
Fig. 39 UK market estimates and forecasts, 2018 - 2030
Fig. 40 Germany
Fig. 41 Germany market estimates and forecasts, 2018 - 2030
Fig. 42 Netherlands
Fig. 43 Netherlands market estimates and forecasts, 2018 - 2030
Fig. 44 Switzerland
Fig. 45 Switzerland market estimates and forecasts, 2018 - 2030
Fig. 46 Italy
Fig. 47 Italy market estimates and forecasts, 2018 - 2030
Fig. 48 France
Fig. 49 France market estimates and forecasts, 2018 - 2030
Fig. 50 Poland
Fig. 51 Poland market estimates and forecasts, 2018 - 2030
Fig. 52 Czech Republic
Fig. 53 Czech Republic market estimates and forecasts, 2018 - 2030
Fig. 54 Croatia
Fig. 55 Croatia market estimates and forecasts, 2018 - 2030
Fig. 56 Market share of key market players- Europe cannabidiol market